Overview

A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The researchers want to collect data on safety and efficacy of combined pulsed dye laser and rapamycin to improve fading/blanching of port wine stain birthmarks as compared to pulsed dye laser alone, which is the current standard of care. This single center pilot and feasibility study will have a target enrollment of 40 port wine stain subjects at the Beckman Laser Institute and Medical Clinic, University of California, Irvine.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, Irvine
Collaborators:
Beckman Laser Institute University of California Irvine
Pfizer
Treatments:
Everolimus
Sirolimus